PubMed=6890814; DOI=10.1016/0006-2952(82)90096-x
Strobel-Stevens J.D., El Dareer S.M., Trader M.W., Hill D.L.
Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
Biochem. Pharmacol. 31:3133-3137(1982)

PubMed=6541096
Eastman A., Illenye S.
Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
Cancer Treat. Rep. 68:1189-1190(1984)

PubMed=3664938; DOI=10.1007/BF00253961
Wilkoff L.J., Dulmadge E.A., Trader M.W., Harrison S.D. Jr., Griswold D.P. Jr.
Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
Cancer Chemother. Pharmacol. 20:96-100(1987)

PubMed=3828995
Richon V.M., Schulte N., Eastman A.
Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
Cancer Res. 47:2056-2061(1987)

PubMed=3167012; DOI=10.1021/bi00413a022
Eastman A., Schulte N.
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).
Biochemistry 27:4730-4734(1988)

PubMed=10200488; DOI=10.1038/sj.cdd.4400357
Segal-Bendirdjian E., Mannone L., Jacquemin-Sablon A.
Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance.
Cell Death Differ. 5:390-400(1998)